STEP: Proglide® Versus Femoseal®: A Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 233 participants.
Also called NCT03192033
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 233 participants
- Sponsor
- Registry
-
NCT03192033
-
- Main results
- A Randomized Trial Comparing Polymer Versus Suture-Based Vascular Closure Devices for Arterial Closure Following Lower-Limb Arterial Endovascular Revascularization
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03192033. Randomized; no masking; primary purpose other. Start 2017-12-04 (actual); primary completion 2019-06-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STEP: Proglide® Versus Femoseal®: A Trial to Compare the Efficacy of Arterial Closure Devices Following Endovascular Peripheral Arterial Procedures
- Acronym
- STEP
- Condition
- Peripheral Arterial Disease
- Intervention (Other)
- Arterial closure to ensure hemostasis at femoral artery puncture points
- Intervention (Device)
- Proglide® (Abbott)
- Intervention (Device)
- Femoseal® (Terumo)
- Intervention (Other)
- Arterial closure to ensure hemostasis at femoral artery puncture points
- Lead sponsor
- Nantes University Hospital
Record details
- Record id
cardio:ct-nct03192033- Content hash
50333a2bbf2ce954033a042470b5257d284026b484cc5bc0a70c17115a1d6f69